Chief Medical Officer
Dr. Bennett is Chief Medical Officer at Adjuvance. He brings 16 years of clinical development experience, including safety assessment of novel vaccine adjuvants. Dr. Bennett has contributed to the licensure of multiple novel vaccines and anti-infectives. Prior to joining Adjuvance, he led clinical development at PaxVax (subsequently acquired by Emergent BioSolutions). Dr. Bennett earned his MD and PhD (Immunology) from the University of Colorado and trained in pediatrics at Dartmouth.